CIK 0001023024 · Large accelerated filer
ANI PHARMACEUTICALS INC
Sign in to watch- Ticker
- ANIP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 582301143
- Phone
- 6097591810
- Business address
- 104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
- Former names
- BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,939,756
- in 9 filings, $1.9M under 10b5-1 plans
Net −$1,939,756. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-29 | Gassert Chad SVP - CORP. DEV. & STRATEGY | Shares withheld for taxes | −1,635 | $67.67 | $111K | 49,679 |
| 2024-02-29 | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS | Shares withheld for taxes | −1,122 | $67.67 | $76K | 68,652 |
| 2024-02-29 | Mutz Christopher HEAD OF RARE DISEASE | Shares withheld for taxes | −1,275 | $67.67 | $86K | 92,387 |
| 2024-02-29 | Gutwerg Ori SVP, GENERICS | Shares withheld for taxes | −1,570 | $67.67 | $106K | 82,706 |
| 2024-02-29 | Lalwani Nikhil PRESIDENT & CEO | Shares withheld for taxes | −10,014 | $67.67 | $678K | 473,946 |
| 2024-02-29 | CAREY STEPHEN P. SVP & CFO | Shares withheld for taxes | −1,914 | $67.67 | $130K | 189,715 |
| 2024-02-29 | Marken James G. SVP OPS & PROD DEV | Shares withheld for taxes | −1,058 | $67.67 | $72K | 148,830 |
| 2024-02-15 | Mutz Christopher HEAD OF RARE DISEASE | Shares withheld for taxes | −1,261 | $57.55 | $73K | 93,662 |
| 2024-02-15 | Gutwerg Ori SVP, GENERICS | Shares withheld for taxes | −1,244 | $57.55 | $72K | 84,276 |
| 2024-02-14 | Davis Krista SVP, CHIEF HR OFFICER | Grant or award | +12,079 | 44,666 | ||
| 2024-02-14 | Davis Krista SVP, CHIEF HR OFFICER | Grant or award | +8,052 | 52,718 | ||
| 2024-02-14 | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | Grant or award | +14,763 | 51,562 | ||
| 2024-02-14 | Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | Grant or award | +9,842 | 61,404 | ||
| 2024-02-14 | Gassert Chad SVP - CORP. DEV. & STRATEGY | Grant or award | +13,421 | 42,368 | ||
| 2024-02-14 | Gassert Chad SVP - CORP. DEV. & STRATEGY | Grant or award | +8,946 | 51,314 | ||
| 2024-02-14 | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS | Grant or award | +13,421 | 60,828 | ||
| 2024-02-14 | Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS | Grant or award | +8,946 | 69,774 | ||
| 2024-02-14 | Mutz Christopher HEAD OF RARE DISEASE | Grant or award | +18,790 | 82,397 | ||
| 2024-02-14 | Mutz Christopher HEAD OF RARE DISEASE | Grant or award | +12,526 | 94,923 | ||
| 2024-02-14 | Gutwerg Ori SVP, GENERICS | Grant or award | +14,763 | 75,678 |
Page 15 of 23 · 442 trades